← All Sponsors
SPONSOR

Richard Stone, MD

Total Trials
1
Recruiting
1
Phases
Phase 1

Richard Stone, MD is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations, AML.

The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Richard Stone, MD

How many clinical trials has Richard Stone, MD sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Richard Stone, MD, of which 1 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Richard Stone, MD research focus on?
Richard Stone, MD clinical trials span Acute Myeloid Leukemia, AML, Adult, AML With Gene Mutations, AML, Leukemia. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Richard Stone, MD clinical trial?
To participate in a Richard Stone, MD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Richard Stone, MD trials with current recruitment status updated daily.

Clinical Trials by Richard Stone, MD

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology